OpenFilings

Immix Biopharma, Inc.

Form10-K/A

Report Period2024-12-31

Date Filed2025-05-19

Time Filed17:19:35

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-31.3
EX-31.4
Filing on SEC Edgar